Buyer beware: What's your new technology FDA approved for?
Credentialing Resource Center Connection, March 26, 2009
Want to receive articles like this one in your inbox? Subscribe to Credentialing Resource Center Connection!
PathoLase is marketing its PinPointe laser as a treatment for toenail fungus even though the product was approved by the Food and Drug Administration (FDA) in 2001 for use in dentistry, according to a March 20 New York Times article.
“Technically, the FDA does not regulate the practice of medicine, so doctors are indeed able to use approved drugs and devices for unapproved purposes when they deem it appropriate,” the article states.
However, it is illegal for companies to market a product for unapproved indications, Timothy A. Ulatowski, director of compliance at the Center for Devices and Radiological Health at the FDA, told The New York Times.
This case brings to light a question that medical staffs need to ask themselves before introducing a new technology at their organization: “Even though it may not be illegal to do so, are we granting practitioners the privilege to use the technology for the purpose for which the FDA approved it?”
Want to receive articles like this one in your inbox? Subscribe to Credentialing Resource Center Connection!
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- HIPAA Q&A: Level of encryption needed for email
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- QA:Coding multiple initial infusions
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: Level of encryption needed for email
- Q&A: Follow CMS' coding guidelines when using modifier -25
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- CMS has reformulated payments for some bilateral procedures
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- ED-to-inpatient transfers are flawed with safety gaps
- Searched
